US equities
|
MU
$1,045.56
▲+0.00%
INTC
$112.50
▲+0.00%
NVDA
$239.24
▲+0.00%
SNDK
$1,660.46
▲+0.00%
SPCX
$171.92
▲+0.00%
MRVL
$287.01
▲+0.00%
AMD
$649.42
▲+0.00%
MSTR
$164.55
▲+0.00%
MU
$1,045.56
▲+0.00%
INTC
$112.50
▲+0.00%
NVDA
$239.24
▲+0.00%
SNDK
$1,660.46
▲+0.00%
SPCX
$171.92
▲+0.00%
MRVL
$287.01
▲+0.00%
AMD
$649.42
▲+0.00%
MSTR
$164.55
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Fennec Pharmaceuticals Inc. - Common Stock
(NQ:
FENC
)
10.35
UNCHANGED
Delayed Quote
Updated: 4:00 PM EDT, Oct 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Fennec Pharmaceuticals Inc. - Common Stock
< Previous
1
2
3
4
Next >
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
↗
June 22, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc...
Via
Benzinga
Fennec Pharma Stock Is Trading Higher As Pedmark Is Under FDA Review For Chemo-Induced Toxicity
↗
June 22, 2021
The FDA has accepted for review Fennec Pharmaceuticals Inc's (NASDAQ: FENC) resubmitted marketing application seeking approval for Pedmark (formulated sodium...
Via
Benzinga
Why Fennec Pharmaceuticals's Stock is Trading Higher Today
↗
April 21, 2021
Fennec Pharmaceuticals's Stock Price And Volume Action Fennec Pharmaceuticals's (NASDAQ:
Via
Benzinga
Fennec Pharma Refiles Pedmark US Application For Cisplatin-Induced Ototoxicity In Pediatric Patients
↗
May 28, 2021
Fennec Pharmaceuticals Inc (NASDAQ: FENC) has resubmitted its marketing application to the FDA seeking approval for Pedmark (formulated sodium thiosulfate) for the...
Via
Benzinga
The Daily Biotech Pulse: Biohaven, Bristol-Myers Squibb Snag FDA Approvals, Iterum UTI Drug Review On Track, Centessa Pharmaceuticals Debuts On Nasdaq
↗
May 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 27) BioCryst Pharmaceuticals,...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2021
↗
April 21, 2021
Upgrades For Cerecor Inc (NASDAQ:CERC), Maxim Group upgraded the previous rating of Hold to Buy. In the fourth quarter, Cerecor showed an EPS of $0.19, compared to $0.10...
Via
Benzinga
51 Biggest Movers From Yesterday
↗
April 07, 2021
Gainers UTime Limited (NASDAQ: UTME) shares jumped 875% to close at $39.00 on Tuesday after the company priced its IPO at $4 per share. Romeo Power, Inc. (NYSE: RMO) climbed 59.6...
Via
Benzinga
Topics
Initial Public Offering
< Previous
1
2
3
4
Next >
